DAIC

APRIL 12, 2024

milla1cf Fri, 04/12/2024 - 20:53 April 12, 2024 — HeartBeam, Inc. , a medical technology company focused on transforming cardiac care through the power of personalized insights, today announced new data demonstrating that applying the company’s artificial intelligence ( AI ) algorithms to vectorcardiography (VCG) showed considerably improved performance in the detection of atrial flutter over single-lead electrocardiograms (ECGs) and similar performance to 12-lead ECGs, the standard for diagno

Atrial Flutter 124

Atrial Flutter Arrhythmia Technology Electrocardiogram 124

Dr. Paddy Barrett

APRIL 12, 2024

Walking more is linked to a longer life at a higher quality. That is something we can all aim for. High levels of aerobic fitness, as measured by V02 max, is one of the most powerful predictors of longevity. But for many people regular exercise at even moderate intensities will not be on the cards. I don’t think that is a good idea, but it will be a reality for many.

Quality of Life 118

Quality of Life Blood Pressure Exercise Chronic Disease 118

DAIC

APRIL 12, 2024

Getty Images milla1cf Fri, 04/12/2024 - 20:55 April 12, 2024 — Simpson Interventions, Inc. , a pioneering medical technology company specializing in cardiovascular interventional devices, today announced that its groundbreaking Acolyte Image Guided Crossing and Re-Entry Catheter System has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration ( FDA ).

Technology 111

Technology Cardiovascular Interventions Coronary Artery Disease Innovation 111

HCPLive

APRIL 12, 2024

Ankeet Bhatt, MD, MBA, discusses a NUDGE-FLU analysis from ACC.24 examining effect of the CV gain-framed nudge in patients with and without history of AMI.

Myocardial Infarction 119

Myocardial Infarction 119

Frontiers in Cardiovascular Medicine

APRIL 12, 2024

Deep brain stimulation (DBS) is an interdisciplinary and reversible therapy that uses high-frequency electrical stimulation to correct aberrant neural pathways in motor and cognitive neurological disorders. However, the high frequency of the waves used in DBS can interfere with electrical recording devices (e.g., electrocardiogram, electroencephalogram, cardiac monitor), creating artifacts that hinder their interpretation.

Electrocardiogram 105

Electrocardiogram 105

HCPLive

APRIL 12, 2024

A new study found extending postpartum Medicaid from 60 days to 12 months is linked to new mothers being more likely to seek mental health care for perinatal mood and anxiety disorders.

Medicaid 105

Medicaid 105

Med Page Today

APRIL 12, 2024

(MedPage Today) -- The European Medicines Agency (EMA) found no evidence to support a causal link between GLP-1 receptor agonists and suicidal thoughts, a committee said on Friday following a 9-month review. An investigation was launched in July.

98

98

Med Page Today

APRIL 12, 2024

(MedPage Today) -- Patients with persistent non-high-density lipoprotein (HDL) cholesterol dyslipidemia from childhood to adulthood had an increased risk of cardiovascular disease (CVD) events, but those who had resolved this by adulthood had a.

Cholesterol 82

Cholesterol Cardiovascular Disease 82

HCPLive

APRIL 12, 2024

Safia Chatur, MD, discusses the results of a PARADIGM-HF analysis at ACC.24 examining the effects of ARNI use across the updated 2024 KDIGO Risk Classifications.

85

85

The New England Journal of Medicine

APRIL 12, 2024

The widening scope and scale of genetic tests are posing new challenges, and the need to address these challenges is becoming immediately relevant for all clinicians, not just genetics experts.

75

75

HCPLive

APRIL 12, 2024

Tracy Frech, MD, MSCI, explains what rheumatologists need to know about preventing and management digital ischemia.

Ischemia 98

Ischemia 98

Cardiometabolic Health Congress

APRIL 12, 2024

Introduction: Addressing the Need for Improved LDL Management in the US There is a clear need for innovative treatments to combat cardiovascular disease (CVD). Heart disease remains the leading cause of death for men and women. 80% of heart attacks and strokes linked to CVD are preventable with optimal risk factor management. However, every 40 seconds, an individual in the US suffers a heart attack.

Myocardial Infarction 64

Myocardial Infarction Cardiovascular Disease Heart Attack Heart attacks 64

HCPLive

APRIL 12, 2024

These data highlight guselkumab’s impact on psoriasis patients’ symptoms and HRQoL, as well as on sexual impairment and perceptions of stigmatization.

76

76

American College of Cardiology

APRIL 12, 2024

Are high-risk plaque (HRP) features on coronary computed tomography angiography (CTA) associated with vulnerable plaque on optical coherence tomography (OCT)?

Plaque 74

Plaque Article 74

Cardiovascular Diabetology

APRIL 12, 2024

The accumulation of visceral and ectopic fat comprise a major cause of cardiometabolic diseases. However, novel drug targets for reducing unnecessary visceral and ectopic fat are still limited. Our study aims.

Research 59

Research 59

American College of Cardiology

APRIL 12, 2024

In this episode, Dr. Jonathan Kim is joined by Drs. Marty Maron, Kim Harmon, and Aaron Baggish to discuss the principles of shared decision-making in the context of sports participation for athletes with heart disease and ‘the why’ to do it.

Heart Disease 66

Heart Disease Article 66

HCPLive

APRIL 12, 2024

Results showed poorly controlled HbA1C increased the risk of elevated ALT levels in children and adolescents with type 1 diabetes, suggesting an important link to MASLD.

Diabetes 59

Diabetes 59

Society of Thoracic Surgeons - Congenital

APRIL 12, 2024

Resource SAVR After TAVR Risk Calculator kchalko Fri, 04/12/2024 - 13:53 SAVR after previous TAVR is the fastest-growing cardiac surgery procedure in the U.S. The majority of patients require explant of their TAVR device and SAVR with significantly increased risk of operative mortality and stroke. These real-world outcomes underlay the updated SAVR risk models, which adjust for prior TAVR.

TAVR 52

TAVR Patient Care Outcomes Research 52

HCPLive

APRIL 12, 2024

A study found MRI treat-to-target strategy does not help bring RA patients to remission, even when also targeting the absence of osteitis alongside clinical remission.

59

59

Journal of Cardiothoracic Surgery

APRIL 12, 2024

Open arch surgery is technically demanding for the surgeon and surgically and biologically invasive for the patient, requiring a variably long period of hypothermic circulatory arrest.

Aortic 52

Aortic 52

HCPLive

APRIL 12, 2024

Kanya Oul shares how her generalized pustular psoriasis (GPP) was initially treated and Drs Tina Bhutani and Scott Boswell discuss available treatment options for GPP.

52

52

Journal of Cardiothoracic Surgery

APRIL 12, 2024

To date, the extended Morrow procedure is considered the gold standard treatment for patients with obstructive hypertrophic cardiomyopathy who experience severe symptoms and are unresponsive to medication trea.

Cardiomyopathy 52

Cardiomyopathy Ablation Outcomes Research 52

HCPLive

APRIL 12, 2024

Treatment with intravenous iron therapy proves more efficacious than oral or no iron therapy in improving hemoglobin in pediatric patients admitted with IBD and IDA.

Pediatrics 52

Pediatrics 52

American College of Cardiology

APRIL 12, 2024

The Centers for Medicare and Medicaid Services (CMS) released the Fiscal Year (FY) 2025 Inpatient Prospective Payment System (IPPS) proposed rule, proposing a 2.6% increase in operating payment rates for applicable hospitals. This represents a 3% projected increase in the hospital market basket update with a projected 0.4% productivity adjustment reduction.

CMS 49

CMS Hospital Medicaid Medicare 49

HCPLive

APRIL 12, 2024

Jinny Tavee, MD, explains the potential neurological complications of sarcoidosis, an autoimmune disease that affects multiple systems.

59

59

HeartRhythm

APRIL 12, 2024

Mavacamten is a cardiac myosin inhibitor that has been shown to reduce left ventricular outflow tract obstruction in obstructive hypertrophic cardiomyopathy (oHCM).1 In late-stage clinical trials, atrial fibrillation (AF) represented an adverse event in 2-4 % of the patients randomized to mavacamten.1,2 However, the effect of mavacamten on the frequency and management of new/recurrent AF episodes in oHCM receiving mavacamten following its Food and Drug Administration (FDA) approval remains only

Atrial Fibrillation 40

Atrial Fibrillation Cardiomyopathy 40

HCPLive

APRIL 12, 2024

These data highlight the frequency of adverse events with narrow-band UVB phototherapy and concomitant therapy.

64

64

Journal of Cardiothoracic Surgery

APRIL 12, 2024

There are enough cases of colorectal cancer with liver metastasis, but inferior vena cava infiltraion with dissemination to the right atrium is an infrequent event.

Pulmonary 40

Pulmonary Cancer 40

HCPLive

APRIL 12, 2024

Although overall engagement in the HCV care cascade improved after the introduction of DAAs, vulnerable subgroups still received less testing and treatment.

52

52

Society of Thoracic Surgeons - Congenital

APRIL 12, 2024

STS Launches New Valve Surgery Risk Calculators KCummings Fri, 04/12/2024 - 09:35

40

40

HCPLive

APRIL 12, 2024

Experts highlight how a history of cancer may impact psoriasis treatment decisions while touching on the safety profiles of newer IL agents.

Cancer 52

Cancer 52

Stroke Journal

APRIL 12, 2024

Stroke, Ahead of Print.

Stroke 40

Stroke Strokes 40

HCPLive

APRIL 12, 2024

Dr Scott Boswell highlights how he differentiates between generalized pustular psoriasis (GPP) and other dermatologic conditions.

52

52

DAIC

APRIL 12, 2024

UVA's Kenneth Walsh, PhD, and his team have discovered how Y chromosome loss triggers changes in heart immune cells that make the cells more likely to cause scarring and heart failure. Image courtesy of Dan Addison | UVA Communications milla1cf Fri, 04/12/2024 - 20:50 April 12, 2024 — University of Virginia School of Medicine researchers have discovered a gene on the Y chromosome that contributes to the greater incidence of heart failure in men.

Heart Failure 111

Heart Failure Research Heart Disease Document 111

HCPLive

APRIL 12, 2024

A clinical pharmacist discusses the role of pharmacy benefit managers and payers in accessibility of adalimumab biosimilars.

52

52

HCPLive

APRIL 12, 2024

Dermatology physician assistants review the laboratory and monitoring requirements for TYK2 inhibitors deucravacitinib.

Laboratory 52

Laboratory 52

HCPLive

APRIL 12, 2024

Experts discuss common comorbidities for patients with plaque psoriasis and how they can impact treatment decisions.

Plaque 52

Plaque 52